Advertisement
Advertisement

CNTA

CNTA logo

Centessa Pharmaceuticals plc - ADR

39.59
USD
Sponsored
-0.01
-0.01%
May 15, 12:12 UTC -4
Open

Centessa Pharmaceuticals plc - ADR Profile

About

Centessa Pharmaceuticals plc is a clinical-stage company employing its innovative asset-centric business model to discover, develop and ultimately deliver impactful medicines to patients. Centessa Pharmaceuticals plc is based in Cambridge, United Kingdom.

Info & Links

CEO

Mario Alberto Accardi

Headquarters

3rd Floor, 1 Ashley Road, Altrincham
Cheshire, X0 WA14 2DT, UNITED KINGDOM

Industry

Medical Drugs

Sector

Medical

Website

www.centessa.com

Auditor

KPMG LLP

Share holders

4

Employees

118

Centessa Pharmaceuticals plc - ADR Statistics

Valuation Measures

Market Capitalization2

6.13B

Enterprise Value

6.18B

Enterprise Value/EBITDA(ttm)

-30.03

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

10.14

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-43.56%

Return on Equity(ttm)

-50.66%

Return on Invested Capital(ttm)

-40.08%

Return on Assets(ttm)

-36.65%

Income Statement

Revenue(ttm)

15.00M

Revenue Per Share(ttm)

0.10

Gross Profit(ttm)

15.00M

EBITDA(ttm)3

-205.62M

Net Income Available to Common(ttm)

-197.53M

Diluted EPS(ttm)

-1.47

Share Statistics

Beta (5Y Monthly)

1.25

52-Week Change

222.70%

S&P 500 52-Week Change

25.63%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

154.57M

Dividend Yield

0.00%

Float4

143.61M

% Held by Insiders

7.09%

% Held by Institutions

82.01%

Balance Sheet

Total Cash(mrq)

294.58M

Total Cash Per Share(mrq)

1.91

Total Debt(mrq)

110.09M

Total Debt/Equity(mrq)

20.90%

Current Ratio(mrq)

8.57%

Quick Ratio(mrq)

8.57%

Book Value Per Share(mrq)

3.53

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.43

Free Cash Flow(ytd)

-194.19M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement